does tirzepatide help blood pressure How Supports Cardiovascular Health Tirzepatide Injections for Medical Weight
Description
The MHRA SmPC highlights that GLP-1 receptor agonists may increase the risk of gallbladder disorders, including gallstones (cholelithiasis) and inflammation of the gallbladder (cholecystitis)
Both help with weight management but in unique ways
A Truveta report found that between January 2018 and September of 2023, over a million patients were prescribed a GLP-1 medication and lastly, one in eight or about 13% of American adults, have used a GLP-1 agonist, a class of drugs prescribed predominantly for weight loss to treat metabolic health issues
Unlike previous generations of medications that targeted a single pathway, tirzepatide is a dual agonist
Treatment will include a couple of days stay in the hospital
